Adherence in patients with atrial fibrillation treated with dabigatran
Kardiol Pol
.
2018;76(11):1562-1563.
doi: 10.5603/KP.a2018.0194.
Epub 2018 Sep 13.
Authors
Grzegorz Grześk
1
,
Ewa Janiszewska
,
Bartosz Malinowski
,
Aldona Kubica
,
Michał Wiciński
Affiliation
1
2nd Department of Cardiology, Division of Clinical Pharmacology, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland, 75 Ujejskiego Street, 85-168 Bydgoszcz, Poland. ggrzesk@cm.umk.pl.
PMID:
30211436
DOI:
10.5603/KP.a2018.0194
No abstract available
MeSH terms
Aged
Aged, 80 and over
Antithrombins / therapeutic use
Atrial Fibrillation / complications*
Dabigatran / therapeutic use*
Humans
Middle Aged
Patient Compliance*
Stroke / etiology
Stroke / prevention & control*
Substances
Antithrombins
Dabigatran